Pharmaceutical News

RSS

Hormone replacement therapy formulations may cause different risks for stroke, heart attack

Post-menopausal women whose doctors prescribe hormone replacement therapy for severe hot flashes and other menopause symptoms may want to consider taking low doses of Food and Drug Administration-approved bioidentical forms of estrogen or getting their hormones via a transdermal patch.

20 Sep 2013

UdeM's IRIC and Bristol-Myers Squibb identify small molecule drug candidate against novel target

Universit- de Montr-al and the Institute for Research in Immunology and Cancer - Commercialization of Research today announced that researchers from UdeM's Institute for Research in Immunology and Cancer and Bristol-Myers Squibb Company have jointly identified a small molecule drug candidate against a novel target.

20 Sep 2013

NY Genome Center Marks Its Formal Launch

...

19 Sep 2013

Florida Hospital To Evaluate VTT’S Alzheimer’S Biomarker Assay

VTT Technical Research Centre of Finland is taking an important step toward advancing its Alzheimer's disease biomarker by collaborating with the Florida Hospital Neuroscience Institute to evaluate screening, diagnostic, and prognostic potential of the biomarker assay and utilize it to specifically target which types of precautions to take when approaching early stages of the disease.

19 Sep 2013

Federal judge passes consent order against Shamrock Medical for distributing mislabeled drugs

The U.S. Food and Drug Administration announced today that federal judge Algenon L. Marbley of the Southern District of Ohio has approved a consent decree of permanent injunction against Shamrock Medical Solutions Group, LLC, of Lewis Center, Ohio, and four of its corporate officers and employees for continued drug manufacturing and labeling violations that resulted in the distribution of mislabeled drugs.

19 Sep 2013

Scientists prepare to test vaccines to protect against new bird flu strain

Scientists at Group Health Research Institute are preparing for the potential pandemic spread of a new bird flu strain that caused severe disease in China earlier this year, joining researchers from seven other Vaccine and Treatment Evaluation Units funded by the National Institutes of Health to test vaccines to protect against the illness in adults.

19 Sep 2013

Inhaled corticosteroid increases risk for pneumonia reoccurrence

A University of Alberta researcher says health professionals should be cautious about prescribing inhaled corticosteroids to high-risk patients such as pneumonia survivors, citing a twofold risk for repeat infection.

19 Sep 2013

Scientists develop experimental vaccine against human CMV infection

An experimental vaccine against human cytomegalovirus (CMV) infection, which endangers the developing fetus, organ transplant recipients, patients with HIV and others who have a weakened immune system, proved safe and more effective than previous vaccines developed to prevent infection by the ubiquitous virus.

19 Sep 2013

GSK Returns Vercirnon Rights To Chemocentryx After Phase III Flop

...

18 Sep 2013

AAPM commends FDA’s move to introduce labeling changes on ER/LA opioids

The physicians of the American Academy of Pain Medicine (AAPM) hailed long-awaited labeling changes and other steps taken by the U.S. Food and Drug Administration (FDA) last week to enhance safety in the prescribing of extended-release and long-acting (ER/LA) opioids.

18 Sep 2013

Efficacy and safety data on linagliptin and investigational compound empagliflozin* in various diabetes subpopulations presented by Boehringer Ingelheim and Eli Lilly and Company

Boehringer Ingelheim and Eli Lilly and Company today announced they will feature five oral and 12 poster presentations for linagliptin and the investigational compound empagliflozin* at the 49th Annual Meeting of the European Association for the Study of Diabetes (EASD) which will take place in Barcelona, from 23 – 27 September. The presentations will add to the already existing body of data on safety and efficacy of these two compounds.

18 Sep 2013

Test evaluates benefits of fully dissolvable and temporary drug eluting stent to open heart artery blockages

The Mount Sinai Medical Center is participating in the nationwide ABSORB III clinical trial testing the performance and potential clinical benefits of a fully dissolvable and temporary drug eluting stent to open heart artery blockages.

18 Sep 2013

Cleveland Clinic creates spin-off company to develop vaccine for preventing breast cancer

Cleveland Clinic Innovations has created a spin-off company to develop a preventive breast cancer vaccine based on research from Cleveland Clinic's Lerner Research Institute.

18 Sep 2013

VBP15 drug shows early promise for treatment of Duchenne muscular dystrophy

A preclinical study led by researchers at Children's National Medical Center has found that a new oral drug shows early promise for the treatment of Duchenne muscular dystrophy.

18 Sep 2013

FDA grants Breakthrough Therapy designation to Boehringer Ingelheim's volasertib

Boehringer Ingelheim Pharmaceuticals, Inc. today announced the FDA has granted Breakthrough Therapy designation to volasertib, an investigational inhibitor of polo-like kinase, being evaluated for the treatment of patients aged 65 or older with previously untreated acute myeloid leukemia, ineligible for intensive remission induction therapy.

17 Sep 2013

PCI announces innovative developments in its anti counterfeiting initiatives for pharmaceutical packaging

Packaging Coordinators, Inc. (PCI), a global supplier of pharmaceutical commercial packaging solutions and clinical trials services today announces innovative developments in its anti counterfeiting initiatives for pharmaceutical packaging. The company’s new service offering is outlined in a new white paper that is available to download via PCI anti-counterfeiting white paper and details its innovative identification solution, which uses a unique identification code on each pack, generated and applied by the packer.

From Packaging Coordinators Inc. (PCI) 17 Sep 2013

BMS Licenses Peptidream Technology, Extends Collaboration

...

17 Sep 2013

Research findings unravel phytonutrient gaps worldwide

Amway's Nutrilite Health Institute today presented preliminary global phytonutrient research findings which suggest that people around the world may lack different key phytonutrients in their diets due to low global fruit and vegetable intakes.

17 Sep 2013

TSRI scientists find new way to boost effectiveness of anticancer drugs

Scientists at The Scripps Research Institute (TSRI) have found a way to make dramatic improvements to the cancer cell-killing power of vinblastine, one of the most successful chemotherapy drugs of the past few decades.

17 Sep 2013

Researchers develop new variety of corked microbottle for drugs

Sustained-release formulations that release drugs over longer periods of time are not the final step in the evolution of “intelligent” drug delivery systems. Modern pharmaceuticals are being designed to be released only in a specific, diseased organ; on cues from our circadian rhythm; or under specific physiological conditions.

17 Sep 2013

Pharmaceutical News

Hormone replacement therapy formulations may cause different risks for stroke, heart attack

UdeM's IRIC and Bristol-Myers Squibb identify small molecule drug candidate against novel target

NY Genome Center Marks Its Formal Launch

Florida Hospital To Evaluate VTT’S Alzheimer’S Biomarker Assay

Federal judge passes consent order against Shamrock Medical for distributing mislabeled drugs

Scientists prepare to test vaccines to protect against new bird flu strain

Inhaled corticosteroid increases risk for pneumonia reoccurrence

Scientists develop experimental vaccine against human CMV infection

GSK Returns Vercirnon Rights To Chemocentryx After Phase III Flop

AAPM commends FDA’s move to introduce labeling changes on ER/LA opioids

Efficacy and safety data on linagliptin and investigational compound empagliflozin* in various diabetes subpopulations presented by Boehringer Ingelheim and Eli Lilly and Company

Test evaluates benefits of fully dissolvable and temporary drug eluting stent to open heart artery blockages

Cleveland Clinic creates spin-off company to develop vaccine for preventing breast cancer

VBP15 drug shows early promise for treatment of Duchenne muscular dystrophy

FDA grants Breakthrough Therapy designation to Boehringer Ingelheim's volasertib

PCI announces innovative developments in its anti counterfeiting initiatives for pharmaceutical packaging

BMS Licenses Peptidream Technology, Extends Collaboration

Research findings unravel phytonutrient gaps worldwide

TSRI scientists find new way to boost effectiveness of anticancer drugs

Researchers develop new variety of corked microbottle for drugs

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Latest News